File(s) under permanent embargo
Reason: This item is currently closed access.
Benefits and Harms of Once-weekly Glucagon-like peptide-1 receptor agonist treatments. A systematic review and network meta-analysis
journal contribution
posted on 2015-10-27, 15:57 authored by Melanie J. Davies, Francesco Zaccardi, Zin Zin Htike, David R. Webb, Kamlesh KhuntiBenefits and Harms of Once-weekly Glucagon-like peptide-1 receptor agonist treatments. A systematic review and network meta-analysis
History
Citation
Annals of Internal Medicine, 2015, in pressAuthor affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular SciencesVersion
- AM (Accepted Manuscript)